Mechanisms of cancer cachexia

Hematology/Oncology Clinics of North America

Volumn 5, Issue 1, 1991, Pages 103-123

  Langstein, H N ^a   Norton, J A ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 6;

CACHEXIA; CANCER PATIENT; HUMAN; PHARMACOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0026027679     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0889-8588(18)30457-x     Document Type: Review

References (108)

1. Abbruzzese J.L. Levin B. Ajani J.A. Phase I. Trial of recombinant human 7 interferon and recombinant human tumor necrosis factor in patients with advanced gastrointestinal cancer Cancer Res 49 1989 4057
2. Aderka D. Fisher S. Levo V. Cachectin/tumour necrosis factor production by cancer patients Lancet 2 1985 1190
3. Balducci L. Hardy C. Cancer and nutrition: A review Compr Ther 13 1987 60
4. Balkwill F. Osborne R. Burke F. Evidence for tumour necrosis factor/cachectin production in cancer Lancet 2 1987 1229
5. Beck S.A. Tisdale M.J. Nitrogen excretion in cancer cachexia and its modification by a high fat diet in mice Cancer Res 49 1989 3800
6. Beck S.A. Tisdale M.J. Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host Cancer Res 47 1987 5919
7. Bendtzen E.K. Interleukin 1α, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity Immunol Lett 19 1988 183
8. Beutler B. Cachexia: A fundamental mechanism Nutr Rev 46 1988 369
9. Beutler B. Tumor necrosis, cachexia, shock and inflammation: A common mediator Annu Rev Biochem 57 1988 505
10. Beutler B. Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin Nature 320 1986 584
11. Beutler B. Cerami A. The common mediator of shock, cachexia and tumor necrosis Adv Immunol 42 1988 213
12. Beutler B. Mahoney J. LeTrang N. Purification of cachectin, a lipoprotein lipase suppressive hormone secreted by endotoxin-induced RAW 264.7 cells J Exp Med 161 1985 984
13. Beutler B. Milsark I.W. Cerami A.C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin Science 229 1985 869
14. Bibby M.C. Double J.A. Ali S.A. Characterization of a transplantable adenocarcinoma of the mouse colon producing cachexia in recipient animals J Natl Cancer Inst 78 1987 539
15. Billian A. Gamma-interferon: The match that lights the fire? Immunology Today 9 1988 37
16. Blick M. Sherwin S.A. Rosenblum M. Phase I study of recombinant tumor necrosis factor in cancer patients Cancer Res 47 1987 2986
17. Body J.J. Borkowski A. Nutrition and quality of life in cancer patients Eur J Cancer Clin Oncol 23 1987 127
18. Bozzetti F. Effects of artificial nutrition on the nutritional status of cancer patients JPEN 13 1989 406
19. Bozzetti F. Migliavacca S. Pupa A. Total parenteral nutrition prevents further nutritional deterioration in patients with cancer cachexia Ann Surg 205 1987 138
20. Brennan M.F. Total parenteral nutrition in the cancer patient N Engl J Med 305 1981 375
21. Brouckaert P. Spriggs D.R. Demetri G. Circulating interleukin 6 during a continuous infusion of tumor necrosis factor and interferon-γ J Exp Med 169 1989 2257
22. Buss C.L. Nutritional support of the cancer patient Primary Care 14 1987 317
23. Carter D.B. Deibel M.R. Jr. Dunn C.J. Purification, cloning, expression and biological characterization of an interleukin-1 receptor antagonist protein Nature 344 1990 633
24. Cerami A. Beutler B. The role of cachectin/TNF in endocrine shock and cachexia Immunology Today 5 1988 28
25. Chlebowski R.T. Bulcavage L. Grosvenor M. Hydrazine sulfate influence on nutritional status and survival in non–small-cell lung cancer J Clin Oncol 8 1990 9
26. Darling G. Fraker D.L. Jensen J.C. Cachectic effects of recombinant human tumor necrosis factor in rats Cancer Res 50 1990 4008
27. Detsky A.S. Baker J.P. O’Rourke K. Goel V. Perioperative parenteral nutrition: A meta-analysis Ann Intern Med 107 1987 195
28. DeWvs W.D. Begg D. Lavin P.T. Prognostic effect of weight loss prior to chemotherapy in cancer patients Am J Med 69 1985 491
29. DeWys W. Management of cancer cachexia Sernin Oncol 12 1985 452
30. Engan T. Krane J. Kepp O. Kvinnsland S. Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer N Engl J Med 322 1990 949
31. Fearon K.C.H. Carter D.C. Cancer cachexia Ann Surg 208 1988 1
32. Fearon K.C.H. Borland W. Preston T. Cancer cachexia: Influence of systemic ketosis on substrate levels and nitrogen metabolism Am J Clin Nutr 47 1988 42
33. Fossel E.T. Carr J.M. McDonagh J. Detection of malignant tumors by nuclear magnetic resonance spectroscopy of plasma N Engl J Med 316 1987 1415
34. 2-IFN/IL-6 in man J Immunol 142 1989 2321
35. Fraker D.L. Merino M.J. Norton J.A. Reversal of the toxic effects of cachectin by concurrent insulin administration Am J Physiol 256 1989 E725
36. Gelen J. Moldawer L.L. Lonnroth C. Appearance of hybridoma growth factor/interleukin-6 in the serum of mice bearing a methylcholanthrene-induced sarcoma Biochem Biophys Res Commun 157 1988 575
37. Gold J. Proposed treatment of cancer by inhibition of gluconeogenesis Oncology 22 1968 185
38. Grimble R.T. Cytokines: Their relevance to nutrition Eur J Clin Nutr 43 217 1989
39. Hasseigren P. James H. Benson D.W. Is there a circulating proteolysis-inducing factor during sepsis? Arch Surg 125 1990 510
40. Hellerstein M.K. Meyandi S.N. Meydani M. Interleukin-l-induced anorexia in the rat J Clin Invest 84 1989 228
41. Hesse D.G. Tracey K.J. Fong Y. Cytokine appearance in human endotoxemia and primate bacteremia Surg Gynecol Obstet 166 1988 147
42. Holmes S. Dickerson J.W.T. Malignant disease: Nutritional implications of disease and treatment Cancer Metastasis Rev 6 1987 357
43. Holroyde C.P. Reichard G.A. General metabolic abnormalities in cancer patients: Anorexia and cachexia Surg Clin North Am 66 1986 947
44. Jablons D.M. Mcintosh J.K. Mule J.J. Induction of interferon-2/interleukin-6 (IL-6) by cytokine administration and detection of circulating interleukin-6 in the tumor bearing state Ann NY Acad Sei 557 1989 157
45. Jeevanandam M. Legaspi A. Lowry S.F. Effect of total parenteral nutrition on whole body protein kinetics in cachectic patients with benign or malignant disease JPEN 12 1988 229
46. Jensen J.C. Buresh C.M. Fraker D.L. Enhanced hepatic cytokine gene expression in cachectic tumor bearing rats Surg Forum 41 1990 469
47. Kern K.A. Norton J.A. Cancer cachexia JPEN 12 1988 286
48. Koerner T.J. Adams D.O. Hamilton T.A. Regulation of tumor necrosis factor (TNF) expression: Interferon enhances the accumulation of mTNA for TNF induced by lipopolysaccharide in murine peritoneal macrophages Cell Immunol 109 1987 437
49. Kokal W.A. The impact of antitumor therapy on nutrition Cancer 55 1985 273
50. Koretz R.L. Parenteral nutrition: Is it oncologically logical? J Clin Oncol 2 1984 534
51. Kriegler M. Perez C. DeFay K. A novel form of TNF/cachectin is a cell surface cytotoxic trans-membrane protein: Ramifications for the complex physiology of TNF Cell 53 1988 45
52. Kurzer M. Meguid M.M. Cancer and protein metabolism Surg Clin North Am 66 1986 969
53. Langstein H.W. Fraker D.L. Norton J.A. Reversal of cancer cachexia by antibodies to interferon-gamma but not cachectin/tumor necrosis factor Surg Forum 15 1989 408
54. Larrick J.W. Native interleukin-1 inhibitors Immunology Today 10 1989 61
55. McGeer A.J. Detsky A.S. O'Rourke K. Parenteral nutrition in patients receiving cancer chemotherapy Ann Intern Med 110 1989 734
56. Mcintosh J.K. Jablons D.M. Mule J.J. In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice J Immunol 143 1989 162
57. Masumo H. Yamasak N. Okuda H. Purification and characterization of a lipolytic factor (toxohormone-L) from cell free fluid of ascites sarcoma 180 Cancer Res 41 1981 284
58. Merrick H.W. Long C.L. Grecos G.P. Energy requirements for cancer patients and the effect of total parenteral nutrition JPEN 12 1988 8
59. Mitchell L.A. Norton L.W. Effect of cancer plasma on skeletal muscle metabolism J Surg Res 47 1989 423
60. Mori M. Yamaguchi K. Abe K. Purification of a lipoprotein-lipase inhibiting protein produced by a melanoma cell line associated with cancer cachexia Biochem Biophys Res Commun 3 1988 1085
61. Moldawer L.L. Andersson C. Gelin J. Regulation of food intake and hepatic protein synthesis by recombinant derived cytokines Am J Physiol 254 1988 G450
62. Moldawer L.L. Droft C. Lundholm K. Monocytic production and plasma bioactivities of interleukin-1 and tumor necrosis factor in human cancer Eur J Clin Invest 18 1988 486
63. Moldawer L.L. Georgieff M. Lundholm K. Interleukin 1, tumor necrosis factor-alpha/cachectin and the pathogenesis of cancer cachexia Clin Physiol 7 1987 263
64. Moldawer L.L. Marano M.A. Wei H. Cachectin/tumor necrosis factor alters redblood cell kinetics and induces anemia in vivo FASEBJ 3 1989 1637
65. Moley J.F. Morrison S.D. Norton J.A. Preoperative insulin reverses cachexia and decreases mortality in tumor-bearing rats J Surg Res 43 1987 21
66. Moley J.F. Morrison S.D. Gorschboth C.M. Norton J.A. Body composition changes in rats with experimental cancer cachexia: Improvement with exogenous insulin Cancer Res 48 1988 2784
67. Morrison S.D. Moley J.F. Norton J.A. Contribution of inert mass to experimental cancer cachexia in rats J Natl Cancer Inst 73 1984 991
68. Mulé J.J. Mcintosh J.K. Jablons D.M. Antitumor activity of recombinant interleukin 6 in mice J Exp Med 171 1990 629
69. Nathan C. Secretory products of macrophages J Clin Invest 79 1987 319
70. Neta R. Vogel S.N. Sipe J.D. Comparison of in vitro effects of human recombinant IL-1 and human recombinant IL-6 in mice Lymphokine Res 7 1988 403
71. Nixon D.W. The value of parenteral nutrition support Cancer 58 1986 1902
72. Norton J.A. Moley J.F. Green M.V. Parabiotic transfer of cancer anorexia/cachexia in male rats Cancer Res 45 1985 5547
73. Norton J.A. Peacock J.L. Morrison S.D. Cancer cachexia CRC Crit Rev Oncol/Hematol 7 1987 289
74. Okunieff P. Zietman A. Kahn J. Lack of efficacy of water-suppressed proton nuclear magnetic resonance spectroscopy of plasma for the detection of malignant tumors N Engl J Med 322 1990 953
75. Okusawa S. Gelfand J.A. Ikejima T. Interleukin 1 induces a shock-like state in rabbits J Clin Invest 81 1988 1162
76. Oliff A. The role of tumor necrosis factor (cachectin) in cachexia Cell 54 1988 141
77. Oliff A. Defeo-Jones D. Boyer M. Tumors secreting human TNF/cachectin induce cachexia in mice Cell 50 1987 555
78. Padilla G.V. Psychological aspects of nutrition and cancer Surg Clin North Am 60 1986 1121
79. Patton J.S. Peters P.M. McCabe J. Development of partial tolerance to the gastrointestinal effects of high doses of recombinant tumor necrosis factor in rodents J Clin Invest 80 1987 1587
80. Patton J.S. Shepard H.M. Wilking H. Interferons and tumor necrosis factor have similar catabolic effects on 3T3L1 cells Proc Natl Acad Sei USA 83 1986 8313
81. Peacock J.L. Inculet R.I. Corsey R. Resting energy expenditure and body cell mass alterations in noncachectic patients with sarcomas Surgery 102 1987 465
82. Peacock J.L. Gorschboth C.M. Norton J.A. Impact of insulin on doxorubicin-induced host toxicity and tumor regression Cancer Res 47 1987 4318
83. Pelkonen S. Pluschke G. Recombinant interleukin-1 stimulates clearance of Escherichia coli K 1 bacteremia Microbial Pathogenesis 6 1989 415
84. Plata-Salaman C.R. Oomura Y. Kai T. Tumor necrosis factor and interleukin-1: Suppression of food intake by direct action in the central nervous system Brain Res 448 1988 106
85. Pomposelli J.J. Flores E.A. Bistrian B.R. Role of biochemical mediators in clinical nutrition and surgical metabolism JPEN 12 1988 212
86. Revel M. Host defense against infections and inflammations. Role of the multifunctional IL-6/IFN/β2 cytokine Experentia 45 1988 549 Experentia
87. Scuderi P. Lam K.S. Ryan K.J. Raised serum levels of tumour necrosis factor in parasitic infections Lancet 2 1986 1364
88. Sheppard B.C. Venzon D. Fraker D.L. Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor: Anti-cachexia and antitumor effects Cancer Res 50 1990 3928
89. Sherry B.A. Gelin J. Forg Y. Anti cachectin/tumor necrosis factor antibodies attenuate development of cachexia in tumor models FASEBJ 3 1989 1956
90. Socher S.M. Friedman A. Martinez D. Recombinant human tumor necrosis factor induces acute reductions in food intake and body weight in mice J Exp Med 167 1988 1957
91. Stovroff M.C. Fraker D.L. Swedenborg J.A. Norton J.A. Cachectin/tumor necrosis factor — a possible mediator of cancer anorexia in the rat Cancer Res 48 1988 2784
92. Stovroff M.C. Fraker D.L. Travis W.D. Altered macrophage activity and tumor necrosis factor: Tumor necrosis and host cachexia J Surg Res 46 1989 462
93. Stovroff M.C. Fraker D.L. Norton J.A. Cachectin activity in the serum of cachectic tumorbearing rats Arch Surg 124 1989 94
94. Svaninger G. Isaksson O. Lundholm K. Growth hormone and experimental cancer cachexia J Natl Cancer Inst 79 1987 1359
95. Talmadge J.E. Bowersox O. Tribble H. Therapeutic and toxic activity of tumor necrosis factor is synergistic with gamma interferon Pathol Immunopathol Res 8 1989 21
96. Thomson S.R. Hirshberg A. Haffejee A. Resting metabolic rate of esophageal carcinoma patients: A model for energy expenditure measurement in a homogeneous cancer patient JPEN 14 1990 119
97. Tisdale M.J. Brennan R.A. Metabolic substrate utilization by a tumour cell line which induces cachexia in vivo Br J Cancer 54 1986 601
98. Tisdale M.J. Brennan R.A. Fearon K.C. Reduction of weight loss and tumor size in a cachexia model by a high fat diet Br J Cancer 56 1987 39
99. Tisdale M.J. Leung Y.C. Changes in host liver fatty acid synthetase in tumor-bearing mice Cancer Lett 42 1988 231
100. Tracey K.J. Lowry S.F. Cerami A. Physiologic responses to cachectin. CIBA Foundation Symposium 131. Tumor Necrosis Factor and Related Endotoxins 1987 CIBA New York 88
101. Tracey K.J. Fong Y. Hesse D.G. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia Nature 330 1987 662
102. Tracey K.J. Wei H. Manogue K.R. Cachectin/tumor necrosis factor induces cachexia, anemia and inflammation J Exp Med 167 1988 1211
103. Uehara A. Sekiya C. Takasugi Y. Anorexia induced by interleukin 1: Involvement of corticotropin-releasing factor Am J Physiol 257 1989 R613
104. Waage A. Brandtzaeg P. Halstensen A. The complex pattern of cytokines in serum from patients with meningococcal septic shock J Exp Med 169 1989 333
105. Wallach D. Holtmann H. Engelman H. Sensitization and desensitization to the lethal effects of tumor necrosis factor and IL-1 J Immunol 140 1988 2994
106. Watanabe N. Niitsu Y. Yamamuchi N. Antitumor synergism between recombinant human tumor necrosis factor and recombinant human interferon-7 J Biol Response Modifiers 7 1988 24
107. Wong G.C. Clark S.C. Multiple actions of interleukin 6 within a cytokine network Immunology Today 2 1988 137
108. Ziegler E.J. Tumor necrosis factor in humans N Engl J Med 318 1988 1533